Children

Emtricitabine (Emtriva) has been approved for paediatric use in children three months of age and older. Oral solution dosing is 6mg/kg of body weight to a maximum dose of 240mg. Children weighing over 33kg can take a 200mg capsule once daily.

The efficacy and safety of emtricitabine has been demonstrated when used as part of an initial antiretroviral therapy regimen or as second-line therapy.1

References

  1. Saez-Llorens X et al. Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects. Pediatrics 121(4): e827-835, 2008
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.